Cosmos Health Inc (COSM)

$0.50 +0.01 (1.04%)
Market Cap 19.22M
Revenue (ttm) 54.43M
Net Income (ttm) -16.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.73%
Debt to Equity Ratio 0.41
Volume 887,800
Avg Vol 821,808
Day's Range N/A - N/A
Shares Out 34.92M
Stochastic %K 7%
Beta 5.34
Analysts Strong Buy
Price Target $3.00

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvas...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
141 West Jackson Boulevard, Suite 4236, Chicago, United States
Yatoxksy
Yatoxksy Dec. 5 at 4:45 AM
$COSM @Luvmepup — We appreciate your voice here. The more shareholders speak up, the harder it becomes for the company to ignore us. Shareholders are united in wanting transparency.
0 · Reply
Yatoxksy
Yatoxksy Dec. 5 at 4:41 AM
If Siokas cannot answer straightforward governance questions, and needs lawyers to block responses, then that silence is the message. Shareholders expect leadership — not avoidance. $COSM
0 · Reply
DiamondHandsHarold
DiamondHandsHarold Dec. 5 at 1:57 AM
$COSM is growing its pharma and supplement business while modernizing with AI and digital finance. They’ve also opened a crypto treasury and keep stacking ETH, giving the story a fresh angle.
0 · Reply
DiamondHandsHarold
DiamondHandsHarold Dec. 5 at 1:17 AM
$COSM is growing its pharma and supplement business while rolling in AI and digital finance to modernize operations. They’ve also opened a crypto treasury and keep stacking ETH, adding a unique angle to the story.
0 · Reply
Luvmepup
Luvmepup Dec. 5 at 1:12 AM
$COSM Like I've said for years folks, this crooked CEO has nothing for you retail baggies to increase share price other than broken promises and future hopes and dreams that will never come true.
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 10:06 PM
$COSM Down in AH as well. This is not good for tomorrow folks!
0 · Reply
Yatoxksy
Yatoxksy Dec. 4 at 9:30 PM
$COSM Posting here for visibility. Shareholders have asked clear governance questions to @GregSiokas and @CosmosHealthInc. We are still waiting for a response. Will they address these publicly?
0 · Reply
Yatoxksy
Yatoxksy Dec. 4 at 9:25 PM
$COSM Does anyone seriously believe Siokas will respond to any of these questions?
1 · Reply
AvengerTrader
AvengerTrader Dec. 4 at 9:17 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. Watching: $NUKK $COSM $SPRC $CMND is
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 9:05 PM
$COSM Over an 8% gain just went ...
0 · Reply
Latest News on COSM
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

Dec 3, 2025, 12:20 PM EST - 1 day ago

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Dec 2, 2025, 12:15 PM EST - 2 days ago

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Nov 17, 2025, 9:15 AM EST - 17 days ago

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Oct 31, 2025, 10:45 AM EDT - 4 weeks ago

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Oct 21, 2025, 12:10 PM EDT - 6 weeks ago

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Oct 13, 2025, 2:05 PM EDT - 7 weeks ago

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Oct 10, 2025, 8:00 AM EDT - 7 weeks ago

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Oct 3, 2025, 3:56 PM EDT - 2 months ago

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Sep 29, 2025, 8:00 AM EDT - 2 months ago

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Sep 25, 2025, 8:00 AM EDT - 2 months ago

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Sep 22, 2025, 8:00 AM EDT - 2 months ago

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Sep 11, 2025, 8:00 AM EDT - 3 months ago

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Aug 18, 2025, 12:45 PM EDT - 3 months ago

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Aug 12, 2025, 9:50 AM EDT - 4 months ago

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Aug 6, 2025, 9:20 AM EDT - 4 months ago

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Jun 24, 2025, 10:55 AM EDT - 5 months ago

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 2:30 PM EDT - 7 months ago

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 9:30 AM EDT - 7 months ago

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

May 7, 2025, 2:30 PM EDT - 7 months ago

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

May 6, 2025, 1:40 PM EDT - 7 months ago

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Apr 30, 2025, 12:50 PM EDT - 7 months ago

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Apr 16, 2025, 12:45 PM EDT - 8 months ago

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Apr 9, 2025, 1:40 PM EDT - 8 months ago

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Apr 8, 2025, 10:45 AM EDT - 8 months ago

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Feb 26, 2025, 11:30 AM EST - 10 months ago

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Feb 18, 2025, 8:30 AM EST - 10 months ago

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Feb 11, 2025, 10:15 AM EST - 10 months ago

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Feb 10, 2025, 1:30 PM EST - 10 months ago

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Feb 10, 2025, 9:45 AM EST - 10 months ago

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Feb 7, 2025, 10:00 AM EST - 10 months ago

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Feb 6, 2025, 3:50 PM EST - 10 months ago

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Feb 5, 2025, 11:05 AM EST - 10 months ago

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Jan 28, 2025, 11:00 AM EST - 11 months ago

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Jan 27, 2025, 3:50 PM EST - 11 months ago

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 11 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

VRAX

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Jan 22, 2025, 8:00 AM EST - 11 months ago

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Jan 21, 2025, 3:00 PM EST - 11 months ago

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 11 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

VRAX

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Dec 26, 2024, 1:30 PM EST - 1 year ago

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Dec 23, 2024, 9:25 AM EST - 1 year ago

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Nov 15, 2024, 10:20 AM EST - 1 year ago

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Cosmos Health Issues Letter to Shareholders

Nov 12, 2024, 12:00 PM EST - 1 year ago

Cosmos Health Issues Letter to Shareholders

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Nov 1, 2024, 12:30 PM EDT - 1 year ago

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Sep 25, 2024, 9:25 AM EDT - 1 year ago

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Sep 23, 2024, 12:55 PM EDT - 1 year ago

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Sep 23, 2024, 9:00 AM EDT - 1 year ago

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Sep 19, 2024, 3:40 PM EDT - 1 year ago

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Sep 18, 2024, 1:30 PM EDT - 1 year ago

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

VRAX

Yatoxksy
Yatoxksy Dec. 5 at 4:45 AM
$COSM @Luvmepup — We appreciate your voice here. The more shareholders speak up, the harder it becomes for the company to ignore us. Shareholders are united in wanting transparency.
0 · Reply
Yatoxksy
Yatoxksy Dec. 5 at 4:41 AM
If Siokas cannot answer straightforward governance questions, and needs lawyers to block responses, then that silence is the message. Shareholders expect leadership — not avoidance. $COSM
0 · Reply
DiamondHandsHarold
DiamondHandsHarold Dec. 5 at 1:57 AM
$COSM is growing its pharma and supplement business while modernizing with AI and digital finance. They’ve also opened a crypto treasury and keep stacking ETH, giving the story a fresh angle.
0 · Reply
DiamondHandsHarold
DiamondHandsHarold Dec. 5 at 1:17 AM
$COSM is growing its pharma and supplement business while rolling in AI and digital finance to modernize operations. They’ve also opened a crypto treasury and keep stacking ETH, adding a unique angle to the story.
0 · Reply
Luvmepup
Luvmepup Dec. 5 at 1:12 AM
$COSM Like I've said for years folks, this crooked CEO has nothing for you retail baggies to increase share price other than broken promises and future hopes and dreams that will never come true.
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 10:06 PM
$COSM Down in AH as well. This is not good for tomorrow folks!
0 · Reply
Yatoxksy
Yatoxksy Dec. 4 at 9:30 PM
$COSM Posting here for visibility. Shareholders have asked clear governance questions to @GregSiokas and @CosmosHealthInc. We are still waiting for a response. Will they address these publicly?
0 · Reply
Yatoxksy
Yatoxksy Dec. 4 at 9:25 PM
$COSM Does anyone seriously believe Siokas will respond to any of these questions?
1 · Reply
AvengerTrader
AvengerTrader Dec. 4 at 9:17 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. Watching: $NUKK $COSM $SPRC $CMND is
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 9:05 PM
$COSM Over an 8% gain just went ...
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 9:01 PM
$COSM $0.49 😂🤣😂
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 8:55 PM
$COSM After being down 25% this week so far ... can this get back a whole penny?
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 8:36 PM
$COSM Cosmos ... where creating lifelong baggies is what we do best!
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 8:29 PM
$COSM We won't even let this get a dead cat bounce!
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 8:02 PM
$COSM Who bought in the .50's today and now regrets it?
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 7:57 PM
$COSM This crooked CEO refuses to buy a single share on the open market. Instead he keeps adding to the float by acquiring shares in lieu of debt owed to him. That should tell you all you need to know folks..
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 7:52 PM
$COSM Just like clockwork, this is starting to tank towards close. Look at those large sell orders going through ... one right after another!
0 · Reply
john_acc
john_acc Dec. 4 at 7:33 PM
$COSM CEO keeps on buying shares ! Thats the biggest stamp of approval!
0 · Reply
john_acc
john_acc Dec. 4 at 7:32 PM
$COSM "CEO been buying shares" says it all!!!
0 · Reply
tommy45
tommy45 Dec. 4 at 7:25 PM
$COSM believe you see this back up around 90c this month or higher guys. CEO been buying shares and some nice plans are in the pipe line gl
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 7:20 PM
$COSM Red yet?
0 · Reply
Luvmepup
Luvmepup Dec. 4 at 7:02 PM
$COSM Don't become a 0.50 bag holder folks!
0 · Reply